Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Kazia Therapeutics
Kazia Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?